期刊
JOURNAL OF THE NEUROLOGICAL SCIENCES
卷 422, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jns.2021.117309
关键词
Parkinson?s disease; Edited MRS; MEGA-PRESS; Gamma-aminobutyric acid; Brainstem; L-dopa
资金
- National Natural Science Foundation of China [81671668, 81371534]
- Natural Science Foundation of Shandong [ZR2020QH267]
- Major Research Project of Shandong Province [2016ZDJS07A16]
- National Institutes of Health [R01 EB016089, P41 EB015909, K99 EB028828]
This preliminary study found that GABA+ levels in the upper brainstem were significantly increased in PD patients post-L-dopa administration, suggesting that dopaminergic therapy may improve GABA+ levels in the upper brainstem and modulate the GABAergic system in the treatment of PD.
Purpose: Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder, characterized by the dysfunction between dopaminergic and GABAergic neuronal activities. Dopamine (DA) replacement by its precursor L-dopa remains the primary treatment for PD. In this preliminary study, we test the hypotheses that GABA+ levels would be lower in PD patients than controls, and normalized by L-dopa. Methods: Eleven PD patients and eleven age-and gender-matched healthy controls underwent a 1H-MRS scan of the upper brainstem using a J-difference-edited sequence to resolve signals of GABA. PD patients did not take all dopaminergic medicines for at least twelve hours prior to the first scan, and were scanned again after resuming L-dopa (pre-and post-L-dopa). MRS data were processed using the Gannet. Differences of GABA+ (GABA, macromolecules, and homocarnosine) levels within-subject (PD: pre-and post-L-dopa) and between-subjects (HC vs. PD-pre or PD-post) were tested using linear mixed-effects models with Holm-Bonferroni correction applied to pairwise comparisons. Results: Significant increased GABA+ levels were observed in the upper brainstem of PD patients post-L-dopa compared with pre-L-dopa (p < 0.001). Patients' GABA+ levels before administration of L-dopa were significantly lower than HCs (p = 0.001). Increased GABA+ level by administration of L-dopa in PD patients (post-Ldopa) was lower compared with HCs, but not significantly (p = 0.52). Conclusion: Increased GABA+ levels were present in the upper brainstem with PD patients post-L-dopa, suggesting dopaminergic therapy capable of improving dopamine may improve the GABA+ levels in the upper brainstem, thereby achieving the effect of modulating the GABAergic system in the treatment of PD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据